Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

This study has been completed.

Sponsored by:	University Hospital, Rouen
Information provided by:	University Hospital, Rouen
ClinicalTrials.gov Identifier:	NCT00213473

Purpose

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer > 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

Condition
Acquired Haemophilia Register

Genetics Home Reference related topics: hemophilia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

Further study details as provided by University Hospital, Rouen:

Study Start Date:	June 2001
Estimated Study Completion Date:	May 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Factor VIIIc < 30% and Factor VIII inhibitor > 1 u Bethesda

Exclusion Criteria:

absence and signed consent, haemophilia A

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213473

Locations

France
University Hospital of Rouen
Rouen, France, 76031

Sponsors and Collaborators

University Hospital, Rouen

Investigators

Principal Investigator:

Herve LEVESQUE, MD

University Hospital, Rouen

More Information

Study ID Numbers:	2001/001 HP
Study First Received:	September 13, 2005
Last Updated:	June 4, 2007
ClinicalTrials.gov Identifier:	NCT00213473
Health Authority:	France: Afssaps - French Health Products Safety Agency

Keywords provided by University Hospital, Rouen:

acquired haemophilia

Study placed in the following topic categories:

Hemorrhagic Disorders
Genetic Diseases, Inborn
Hematologic Diseases

Blood Coagulation Disorders
Hemophilia A
Hemostatic Disorders

Additional relevant MeSH terms:

Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders

ClinicalTrials.gov processed this record on January 14, 2009